-+ 0.00%
-+ 0.00%
-+ 0.00%

SENTI BIO RECEIVES FDA REGENERATIVE MEDICINE ADVANCED THERAPY (RMAT) DESIGNATION FOR SENTI-202 IN THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

Reuters·12/09/2025 12:00:03

Please log in to view news